170 related articles for article (PubMed ID: 29599067)
1. Editor's Choice - A Comparison of Clinical Outcomes Between Primary Bypass and Secondary Bypass After Failed Plain Balloon Angioplasty in the Bypass versus Angioplasty for Severe Ischaemia of the Limb (BASIL) Trial.
Meecham L; Patel S; Bate GR; Bradbury AW
Eur J Vasc Endovasc Surg; 2018 May; 55(5):666-671. PubMed ID: 29599067
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
Meecham L; Bate G; Patel S; Bradbury AW
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):52-59. PubMed ID: 30786974
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial.
Popplewell MA; Davies HOB; Narayanswami J; Renton M; Sharp A; Bate G; Patel S; Deeks J; Bradbury AW
Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):195-201. PubMed ID: 28602580
[TBL] [Abstract][Full Text] [Related]
4. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
Kodama A; Meecham L; Popplewell M; Bate G; Conte MS; Bradbury AW
Eur J Vasc Endovasc Surg; 2020 Nov; 60(5):687-695. PubMed ID: 32778491
[TBL] [Abstract][Full Text] [Related]
5. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial.
Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Raab G; Ruckley CV
Health Technol Assess; 2010 Mar; 14(14):1-210, iii-iv. PubMed ID: 20307380
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Contemporary Clinical Outcomes Following Femoro-Popliteal Plain Balloon Angioplasty and Bypass Surgery for Chronic Limb Threatening Ischemia.
Meecham L; Popplewell MA; Bate GR; Patel S; Bradbury AW
Vasc Endovascular Surg; 2021 Aug; 55(6):544-550. PubMed ID: 33882737
[TBL] [Abstract][Full Text] [Related]
7. Comparison of femoropopliteal plain balloon angioplasty for chronic limb-threatening ischemia in the BASIL trial and in a UK contemporary series.
Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
J Vasc Surg; 2021 Dec; 74(6):1948-1955. PubMed ID: 34298121
[TBL] [Abstract][Full Text] [Related]
8. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
[TBL] [Abstract][Full Text] [Related]
9. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.
Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
J Vasc Surg; 2010 May; 51(5 Suppl):52S-68S. PubMed ID: 20435262
[TBL] [Abstract][Full Text] [Related]
10. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
J Vasc Surg; 2010 May; 51(5 Suppl):5S-17S. PubMed ID: 20435258
[TBL] [Abstract][Full Text] [Related]
11. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.
Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
J Vasc Surg; 2010 May; 51(5 Suppl):18S-31S. PubMed ID: 20435259
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial.
Benson RA; Meecham LA; Hewitt CA; Bradbury AW
Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):224-228. PubMed ID: 31201136
[TBL] [Abstract][Full Text] [Related]
13. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
Conte MS
J Vasc Surg; 2010 May; 51(5 Suppl):69S-75S. PubMed ID: 20435263
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Outcomes in Patients Selected for Infra-Popliteal Bypass or Plain Balloon Angioplasty for Chronic Limb Threatening Ischemia Between 2009 and 2013.
Popplewell MA; Davies HOB; Meecham L; Bate G; Bradbury AW
Vasc Endovascular Surg; 2020 Sep; 55(1):1538574420953949. PubMed ID: 32909893
[TBL] [Abstract][Full Text] [Related]
15. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
[TBL] [Abstract][Full Text] [Related]
16. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
Bradbury AW; Moakes CA; Popplewell M; Meecham L; Bate GR; Kelly L; Chetter I; Diamantopoulos A; Ganeshan A; Hall J; Hobbs S; Houlind K; Jarrett H; Lockyer S; Malmstedt J; Patel JV; Patel S; Rashid ST; Saratzis A; Slinn G; Scott DJA; Zayed H; Deeks JJ;
Lancet; 2023 May; 401(10390):1798-1809. PubMed ID: 37116524
[TBL] [Abstract][Full Text] [Related]
17. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A;
Trials; 2017 May; 18(1):224. PubMed ID: 28526046
[TBL] [Abstract][Full Text] [Related]
18. Editor's Choice - Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) Prospective Cohort Study and the Generalisability of the BASIL-2 Randomised Controlled Trial.
Popplewell MA; Meecham L; Davies HOB; Kelly L; Ellis T; Bate GR; Moakes CA; Bradbury AW
Eur J Vasc Endovasc Surg; 2024 Jan; 67(1):146-152. PubMed ID: 37778500
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcomes Following Infrapopliteal Plain Balloon Angioplasty in the BASIL Trial (1999-2004) and in a Contemporary Series (2009-2013).
Popplewell MA; Davies HOB; Renton M; Bate G; Patel S; Deeks JJ; Bradbury AW
Vasc Endovascular Surg; 2020 Feb; 54(2):141-146. PubMed ID: 31749415
[TBL] [Abstract][Full Text] [Related]
20. Procedural and 12-month in-hospital costs of primary infra-popliteal bypass surgery, infrapopliteal best endovascular treatment, and major lower limb amputation for chronic limb threatening ischemia.
Popplewell MA; Andronis L; Davies HOB; Meecham L; Kelly L; Bate G; Bradbury AW
J Vasc Surg; 2022 Jan; 75(1):195-204. PubMed ID: 34481898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
